Medtronic receives CE Mark for VitalFlow™ ECMO System, ushering in a new era of critical care in EuropeMedtronic expands its cardiac surgical and respiratory innovation portfolio with the launch of ...

The increasing demand for donor hearts presents both a critical challenge and a significant opportunity for innovation in ...

The Gulf region’s first robotic lung transplant has been performed at Cleveland Clinic Abu Dhabi (CCAD), placing it among ...

ECMO use in cystic fibrosis with severe respiratory failure showed limited survival, highlighting the need for cautious ...

A US study shows a sharp rise in prolonged emergency department stays and boarding times for older US adults, particularly in ...

Series A reports that a novel combination of brain stimulation and personalized coaching significantly increased physical ...

The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

Leonard Calabrese, DO, Paras Karmacharya, MD, MS, and Adam Kilian, MD, explore how the older average age of patients with GCA ...

A new study has found that eating more green vegetables daily could help prevent heart disease in older adults.

During the menopause transition, only one in five women have optimal scores using the American Heart Association's ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Zegfrovy (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...